bioAffinity Technologies regains Nasdaq compliance after bid-price recovery
bioAffinity Technologies said it regained Nasdaq minimum $1.00 bid-price compliance and will remain listed on the Nasdaq Capital Market.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.